Answers

How do GLP-1 vial and pen prices compare with months of supply?

Compare the prescribed product, package, usable supply and billing period together. A vial count or low per-month headline cannot answer all four.

A package is not a standard month

A quote for one vial, one pen or one kit does not establish how long the prescribed treatment lasts. The relevant comparison is the supplied prescription at the clinician-directed dose, with the pharmacy’s storage and use instructions. A bigger vial is not automatically a longer usable supply, and two pens may have different delivery formats.

Keep the medication comparison separate from the payment plan. A provider may collect three months of fees up front but ship medication in separate installments. Another may use “month” to mean a four-week cycle. Neither description tells you to change a dose or keep using a container beyond its instructions.

Collect these details before comparing quotes

DetailWhy it changes the comparison
Exact medication and formulationA branded pen, compounded injection and dissolving tablet are different products.
Package and labeled quantity“One vial” or “one kit” does not specify concentration or prescribed supply.
Pharmacy-confirmed days or weeks suppliedThis is more useful than assuming every advertised month is a calendar month.
Storage, beyond-use date and instructions after openingThe usable period can limit how much of a package can be used as prescribed.
Charge date and shipment schedulePrepayment, dispatch and refill authorization can happen at different times.

Request these details from the clinician or dispensing pharmacist. The checklist helps compare purchase terms; it is not a method for calculating an injection dose.

Why comparing syringe “units” is unsafe

FDA has reported dosing errors with compounded injectable semaglutide, including confusion among milligrams, milliliters and syringe units. Different products can have different concentrations, including products from the same compounder. The same syringe marking therefore cannot be carried from one prescription to another without professional confirmation.

Ask the dispensing pharmacist to explain the exact instructions and appropriate syringe for the prescription received. Do not use another provider’s chart or a price-per-vial calculation to decide how much to inject. FDA also notes that compounded products do not undergo the same premarket review as approved medicines.

Three real examples of different clocks

Nuform Health advertises kits described as 2.5, 3, 4.5, 5 and 6.5 months, depending on the product category. Those kit labels do not establish that every patient receives the same dose or that every vial remains usable for the full advertised period. Confirm the prescription and dispensing instructions alongside the kit total.

Gimme Care lists one- and three-month billing while describing refills every 28 days. Freya Meds explicitly bills monthly subscriptions every 28 days and ships prepaid courses in installments. These details matter when comparing both the annual budget and the amount of medication actually being dispensed at one time.

For a branded example, Lilly’s commercial savings terms define a month of Zepbound single-dose pens as 28 days and up to four pens, while the single-patient-use KwikPen provision uses up to one pen for that period. Package count alone would make those equivalent treatment periods look very different.

Use cost per prescribed period only after the details match

Once the pharmacy confirms the usable supply and the company confirms all included costs, compare the same period for each option. Keep any consultation, membership and delivery charges visible. If the required facts are missing, mark the comparison incomplete rather than filling the gaps with an estimated vial lifespan.

If a dose changes, request a revised supply and cost explanation. Do not stretch treatment by reducing doses, reuse old directions with a new concentration, or assume leftover medication can be used after the pharmacy’s cutoff. Those are questions for the prescribing and dispensing professionals.

Sources and related reading

For provider context, see our LillyDirect review. Manufacturer-program eligibility remains separate from a telehealth company’s own fees.

FDA: compounded semaglutide dosing errors supports the concentration and measurement cautions. Lilly’s Zepbound commercial savings terms (read October 14, 2026) supplies the specific package-period example.

Continue with why a three-month plan may use a different calendar or how to verify the dispensing pharmacy.

General consumer information, not individualized medical advice. Prescribing and medication-use decisions belong with your clinician and pharmacist. How we review.